TGA considers warning labels for complementary medicines

THE Therapeutic Goods Administration (TGA) has confirmed it will consider labelling complementary medicines with a warning to consumers the products have not been tested for efficacy.

Responding to last week’s Australian National Audit Office (ANAO) review of the regulation of complementary medicines, a TGA spokesperson said the administration was “supportive of moves to inform the community that low risk, complementary medicines are not tested by the TGA for efficacy”.

The audit office review found the TGA’s approach to “easy, quick and low cost” market access for sponsors of complementary medicines was abused by companies which flouted the rules up to 90% of the time.

The report said the current approach of basing new listings largely on self-assessment by the medicine’s sponsor “permits inappropriate or misleading claims”. It also said the TGA did not use the lessons learned from post